Ulrich Vischer

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi The prognostic significance of malnutrition as assessed by the Mini Nutritional Assessment (MNA) in older hospitalized patients with a heavy disease burden
    Ulrich M Vischer
    Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva University Hospitals and University of Geneva, Thonex, Switzerland
    Clin Nutr 31:113-7. 2012
  2. doi The prevalence, characteristics and metabolic consequences of renal insufficiency in very old hospitalized diabetic patients
    U M Vischer
    Department of Rehabilitation and Geriatrics, hôpital des Trois Chêne, Geneva University Hospitals, 3, chemin du Pont Bochet, 1226 Thonex, Switzerland
    Diabetes Metab 37:131-8. 2011
  3. doi The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments
    U M Vischer
    Department of Rehabilitation and Geriatrics, Geneva University Hospitals, hôpital des Trois Chêne, Geneva, Switzerland
    Diabet Med 27:918-24. 2010
  4. doi A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly
    U M Vischer
    Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, Geneva University Hospitals, Geneva, Switzerland
    Diabetes Metab 35:168-77. 2009
  5. doi Cardiometabolic determinants of mortality in a geriatric population: is there a "reverse metabolic syndrome"?
    U M Vischer
    Department of Rehabilitation and Geriatrics, hôpital des Trois Chêne, 3, chemin du Pont Bochet, 1226 Thonex, Suisse
    Diabetes Metab 35:108-14. 2009
  6. ncbi von Willebrand factor, endothelial dysfunction, and cardiovascular disease
    U M Vischer
    Department of Cell Physiology and Metabolism and the Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    J Thromb Haemost 4:1186-93. 2006
  7. ncbi [When can the treatment of isolated systolic hypertension be avoided?]
    U M Vischer
    Hôpital de gériatrie 3, ch Du Pont Bochet 1226 Thônex
    Rev Med Suisse 2:942-6. 2006
  8. ncbi [Management of type 2 diabetes in the elderly]
    Ulrich Vischer
    Département de Réhabilitation et de Gériatrie Hôpital de Gériatrie, 1226 Thonex
    Rev Med Suisse Romande 124:121-4. 2004
  9. ncbi von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII)
    U M Vischer
    Department of Internal Medicine, HCU, Geneva, Switzerland
    Thromb Haemost 80:1002-7. 1998
  10. ncbi Insulinemia and leptinemia in geriatric patients: markers of the metabolic syndrome or of undernutrition?
    S Bonin-Guillaume
    Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, Switzerland
    Diabetes Metab 32:236-43. 2006

Collaborators

Detail Information

Publications20

  1. doi The prognostic significance of malnutrition as assessed by the Mini Nutritional Assessment (MNA) in older hospitalized patients with a heavy disease burden
    Ulrich M Vischer
    Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva University Hospitals and University of Geneva, Thonex, Switzerland
    Clin Nutr 31:113-7. 2012
    ..Malnutrition is common in older persons. However, it is unclear whether malnutrition diagnosed with the Mini Nutritional Assessment (MNA) predicts mortality in older hospitalized patients...
  2. doi The prevalence, characteristics and metabolic consequences of renal insufficiency in very old hospitalized diabetic patients
    U M Vischer
    Department of Rehabilitation and Geriatrics, hôpital des Trois Chêne, Geneva University Hospitals, 3, chemin du Pont Bochet, 1226 Thonex, Switzerland
    Diabetes Metab 37:131-8. 2011
    ..We aimed to characterize the determinants and characteristics of renal disease in very old diabetic patients in geriatric care...
  3. doi The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments
    U M Vischer
    Department of Rehabilitation and Geriatrics, Geneva University Hospitals, hôpital des Trois Chêne, Geneva, Switzerland
    Diabet Med 27:918-24. 2010
    ..However, this approach could lead to inappropriate priorities upon ageing, when diabetes may be compounded by malnutrition and reduced insulin resistance...
  4. doi A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly
    U M Vischer
    Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, Geneva University Hospitals, Geneva, Switzerland
    Diabetes Metab 35:168-77. 2009
    ..The prevention, screening and treatment of both conventional diabetic complications and geriatric syndromes should be integrated in a management plan to optimize the patients' overall health status and quality of life...
  5. doi Cardiometabolic determinants of mortality in a geriatric population: is there a "reverse metabolic syndrome"?
    U M Vischer
    Department of Rehabilitation and Geriatrics, hôpital des Trois Chêne, 3, chemin du Pont Bochet, 1226 Thonex, Suisse
    Diabetes Metab 35:108-14. 2009
    ..Diabetes or insulin resistance, overweight, arterial hypertension, and dyslipidaemia are recognized risk factors for cardiovascular (CV) disease. However, their predictive value and hierarchy in elderly subjects remain uncertain...
  6. ncbi von Willebrand factor, endothelial dysfunction, and cardiovascular disease
    U M Vischer
    Department of Cell Physiology and Metabolism and the Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    J Thromb Haemost 4:1186-93. 2006
    ..Such studies could lead to the clinical use of plasma VWF levels to refine the estimation of the cardiovascular risk and of the expected benefit of antithrombotic agents...
  7. ncbi [When can the treatment of isolated systolic hypertension be avoided?]
    U M Vischer
    Hôpital de gériatrie 3, ch Du Pont Bochet 1226 Thônex
    Rev Med Suisse 2:942-6. 2006
    ..The advantages and limitations of anti-hypertensive therapy in the elderly should be discussed individually, respecting the patient's autonomy...
  8. ncbi [Management of type 2 diabetes in the elderly]
    Ulrich Vischer
    Département de Réhabilitation et de Gériatrie Hôpital de Gériatrie, 1226 Thonex
    Rev Med Suisse Romande 124:121-4. 2004
  9. ncbi von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII)
    U M Vischer
    Department of Internal Medicine, HCU, Geneva, Switzerland
    Thromb Haemost 80:1002-7. 1998
    ....
  10. ncbi Insulinemia and leptinemia in geriatric patients: markers of the metabolic syndrome or of undernutrition?
    S Bonin-Guillaume
    Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, Switzerland
    Diabetes Metab 32:236-43. 2006
    ..Prevention of undernutrition and/or adjustment to its consequences should receive higher priority in the care of elderly diabetic patients...
  11. doi Evidence against a direct role of klotho in insulin resistance
    Olivier Lorenzi
    Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    Pflugers Arch 459:465-73. 2010
    ..However, the hypothesis that klotho indirectly regulates insulin sensitivity via FGF23 activation remains to be investigated...
  12. ncbi Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels
    U M Vischer
    Division de Biochimie Clinique, HCUG, Geneva, Switzerland
    Thromb Haemost 77:387-93. 1997
    ..Our results suggest that due to its rapid turnover, the propeptide could provide a sensitive plasma marker of acute endothelial secretion...
  13. ncbi Epinephrine induces von Willebrand factor release from cultured endothelial cells: involvement of cyclic AMP-dependent signalling in exocytosis
    U M Vischer
    Department of Medicine, Centre Medical Universitaire, Geneva, Switzerland
    Thromb Haemost 77:1182-8. 1997
    ....
  14. ncbi Regulated von Willebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells
    U M Vischer
    Division de Biochimie Clinique, Department of Internal Medicine, Geneva, Switzerland
    Arterioscler Thromb Vasc Biol 20:883-91. 2000
    ..Thus, they are likely to play a physiological role in the regulation of endothelial vWF secretion and, therefore, of plasma vWF levels...
  15. ncbi Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)
    J E Kaufmann
    Division of Clinical Biochemistry, Geneva, Switzerland
    J Thromb Haemost 1:682-9. 2003
    ..The mechanism of action of DDAVP on FVIII plasma levels remains to be elucidated. The hemostatic effect of DDAVP likely involves additional cellular effects that remain to be discovered...
  16. doi Protein kinase C-delta mediates von Willebrand factor secretion from endothelial cells in response to vascular endothelial growth factor (VEGF) but not histamine
    O Lorenzi
    Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
    J Thromb Haemost 6:1962-9. 2008
    ..Vascular endothelial growth factor (VEGF) and histamine induce von Willebrand factor (VWF) release from vascular endothelial cells. Protein kinase C (PKC) is involved in the control of exocytosis in many secretory cell types...
  17. ncbi Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors
    S Zarei
    Department of Rehabilitation and Geriatrics, Faculty of Medicine, University of Geneva, 1 rue Michel Servet, 1211 Geneva 4, Switzerland
    J Thromb Haemost 4:1588-95. 2006
    ..We therefore investigated the effect of dopamine on endothelial VWF secretion...
  18. ncbi Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling
    J E Kaufmann
    Division of Clinical Biochemistry, and Department of Geriatric Medicine, Geneva, Switzerland
    J Thromb Haemost 1:821-8. 2003
    ..These results indicate that DDAVP and other cAMP-raising agents can activate eNOS via PI3K-independent Ser1177 phosphorylation in human endothelial cells. This mechanism most likely accounts for DDAVP-induced vasodilation...
  19. ncbi Major lower limb amputations in the elderly observed over ten years: the role of diabetes and peripheral arterial disease
    G A Carmona
    Department of Orthopaedic Surgery, Geneva University Hospitals, Switzerland
    Diabetes Metab 31:449-54. 2005
    ..Major amputation is a dreaded event with high mortality and morbidity. However, few studies have investigated the epidemiology of amputation in the elderly over time, in the face of evolving management and prevention efforts...
  20. ncbi Neuropeptide Y expression, localization and cellular transducing effects in HUVEC
    Antonio P Silva
    Division d Hypertension et de Médecine Vasculaire, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Biol Cell 97:457-67. 2005
    ..The aim of the present study was to establish NPY expression, storage and cellular transducing effects in HUVEC...